PG-011 gel for eczema in teens and adults
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new gel called PG-011 for people with mild to moderate eczema (atopic dermatitis). The gel is applied to the skin, and the study will check if it helps improve symptoms safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 75 years old.
- You have been diagnosed with eczema (atopic dermatitis) for at least 1 year (adults) or 6 months (teens).
- Your eczema is mild or moderate, covering 10% to 20% of your body (not counting your scalp).
- You do not have any active skin infections or other serious skin conditions that could interfere with the study.
- You do not have a weakened immune system, a history of cancer, or a serious heart, liver, or kidney condition.
- If you can become pregnant or father a child, you agree to use effective birth control during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study tests a new gel called VC005 to see if it safely reduces itching, redness, and irritation in people with atopic dermatitis (a chronic skin condition). You'll be randomly assigned to either the new gel or a placebo (inactive gel) and apply it to affected areas over several weeks.
This study tests a new medicine called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis) that hasn't gotten better with standard creams. The goal is to see if it safely reduces itching and skin symptoms.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial tests an investigational cream called GX-03 for adults with moderate to severe eczema (atopic dermatitis). Participants apply the cream to affected skin daily, and the study compares it to a placebo cream to see if it improves symptoms safely.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.